Insmed Incorporated
Clinical trials sponsored by Insmed Incorporated, explained in plain language.
-
New inhaled drug aims to help people with lung scarring breathe easier
Disease control Recruiting nowThis study tests whether a once-daily inhaled medication called treprostinil palmitil can help adults with pulmonary hypertension (high blood pressure in the lungs) caused by interstitial lung disease (lung scarring) walk farther. About 344 participants will receive either the dr…
Phase: PHASE3 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated May 26, 2026 05:51 UTC
-
Study offers ongoing TPIP access for lung hypertension patients
Disease control AVAILABLEThis study gives continued access to the inhaled drug TPIP for people with pulmonary arterial hypertension (PAH) or pulmonary hypertension linked to interstitial lung disease (PH-ILD). Only those who finished earlier open-label studies of TPIP can join. The goal is to keep provid…
Sponsor: Insmed Incorporated • Aim: Disease control
Last updated May 11, 2026 20:49 UTC